The Journal is included in Russian and International Library and Abstract Databases
Russain Science Index (Russia)
EBSCO
DOI Registration Agency (USA)

Use of native type II collagen as part of the multiagent Gibelli Flex Active

DOI: https://doi.org/10.29296/25877305-2018-12-08
Download full text PDF
Issue: 
12
Year: 
2018

T. Potupchik(1), Candidate of Medical Sciences; L. Evert(2), MD; Yu. Akhmeldinova(1) 1-Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University 2-Research Institute of Medical Problems of the North, Branch Office, Federal Research Center «Krasnoyarsk Research Center, Siberian Branch, Russian Academy of Sciences»

The paper reviews studies of the active ingredients of biologically active additive (BAA) in the dietary supplement Gibelli Flex Active. The BAA components have anti-inflammatory, chondroprotective, antioxidant, and immunomodulatory effects in the treatment of patients with osteoarthritis and improve their mobility and quality of life. Gibelli Flex Active has a good safety profile and can be recommended to treat locomotor diseases in patients of any age.

Keywords: 
rheumatology
osteoarthritis
native type II collagen
glucosamine
turmeric (Curcuma longa)
boswellic acids
Gibelli Flex Active



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Alekseeva L.I. Osteoartroz – problema veka // Med. sovet. – 2013; 5: 2–3.
  2. Badokin V.V. Suschestvujut li hondroprotektivnye preparaty? // RMZh. – 2010; 30: 1848.
  3. Dydykina I.S., Dydykina P.S., Alekseeva O.G. Vklad mikroelementov (medi, margantsa, tsinka, bora) v zdorov'e kosti: voprosy profilaktiki i lechenija osteopenii i osteoporoza // Effektivnaja farmakoterapija. – 2013; 38: 42–9.
  4. Karateev A.E., Nasonova V.A. Vozmozhnosti povyshenija effektivnosti i bezopasnosti terapii patsientov s pojasnichnoj bol'ju // Farmateka. – 2013; 13: 75–7.
  5. Ktsoeva E.L., Gatagonova T.M., Ktsoeva S.A. Kombinirovannoe lechenie bol'nyh osteoartrozom kolennogo sustava s ispol'zovaniem vitamina S // Kubanskij nauchn. med. vestn. – 2013; 5 (140): 121–4.
  6. Nasonov E.L. Nesteroidnye protivovospalitel'nye preparaty / M., 2010.
  7. Svetlova M.S. Patogeneticheskoe lechenie osteoartroza kolennyh sustavov // Sovremennaja revmatologija. – 2012; 3: 1–5.
  8. Spirichev V.B. Vitaminy, vitaminopodobnye i mineral'nye veschestva. Spravochnik / M.: Miklom, 2004.
  9. Tret'jak L.N., Gerasimov E.M. Spetsifika vlijanija selena na organizm cheloveka i zhivotnyh (primenitel'no k probleme sozdanija selenosoderzhaschih produktov pitanija) // Vestnik Orenburgskogo gos. universiteta. – 2007; 12 (79): 136–45.
  10. Habarov A.A., Budko E.V., Lushov K.A. i dr. Tsink: aktual'nost' i harakteristiki biodobavok (obzor literatury) // Sovremennye problemy nauki i obrazovanija. – 2012; 3: [Elektronnyj resurs]. Rezhim dostupa http://science-education.ru/ru/article/view?id=6416
  11. Ausar S., Beltramo D., Castagna L. et al. Treatment of rheumatoid arthritis by oral administration of bovine tracheal type II collagen // Rheumat. Internat. – 2001; 20: 138–44.
  12. Bagchi D., Misner B., Bagchi M. et al. Effects of orally administered undenatured type II collagen against arthritic inflammatory diseases: a mechanistic exploration // Int. J. Clin. Pharmacol. Res. – 2002; 22: 101–10.
  13. Bakilan F., Armagan O., Ozgen M. et al. Effects of Native Collagen Type II Treatment // Eurasian J. Med. – 2016; 48: 95–101.
  14. Crowley D., Lau F., Sharma P. et al. Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial // Int. J. Med. Sci. – 2009; 6: 312–21.
  15. Deberg M., Labasse A., Collette J. et al. One-year increase of Coll 2-1, a new marker of type II collagen degradation, in urine is highly predictive of radiological OA progression // Osteoarthritis Cartilage. – 2005; 13: 1059–65.
  16. Deberg M., Dubuc J., Labasse A. et al. One-year follow-up of Coll2-1, Coll2-1NO2 and myeloperoxydase serum levels in osteoarthritis patients after hip or knee replacement // Ann. Rheum. Dis. – 2008; 67: 168–74.
  17. Evcik D., Babaoğlu Ü. Osteoartrit Etyopatojenezi. Saridoğan M. (Editor). TanidanTedaviyeOsteoartrit / İstanbul: Nobel Tip Kitapevleri, 2007; 51–72.
  18. Jobin C., Bradham C., Russo M. et al. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity // J. Immunol. – 1999; 163: 3474–83.
  19. Jurenka J. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research // Altern. Med. Rev. – 2009; 14 (2): 141–53.
  20. Huebner J., Williams J., Deberg M. et al. Collagen fibril disruption occurs early in primary guinea pig knee osteoarthritis // Osteoarthritis Cartilage. – 2010; 18: 397–405.
  21. Kimmatkar N., Thawani V., Hingorani L. et al. Efficacy and tolerability of Boswelliaserrata extract in treatment of osteoarthritis of knee – A randomized double blind placebo controlled trial // Phytomedicine. – 2003; 10: 3–7.
  22. Kobayashi N., Kostka G., Garbe J. et al. A comparative analysis of the fibulin protein family. Biochemical characterization, binding interactions, and tissue localization // J. Biol. Chem. – 2007; 282: 11805–16.
  23. Meulenbelt I., Kloppenburg M., Kroon H. et al. Urinary CTX-II levels are associated with radiographic subtypes of osteoarthritis in hip, knee, hand, and facet joints in subject with familial osteoarthritis at multiple sites: the GARP study // Ann. Rheum. Dis. – 2006; 65: 360–5.
  24. Scarpellini M., Lurati A., Vignati G. et al. Biomarkers, type II collagen, glucosamine and chondroitin sulfate in osteoarthritis follow-up: the «Magenta osteoarthritis study» // J. Orthopaed. Traumatol. – 2008; 9: 81–7.
  25. Sellam J., Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis // Nat. Rev. Rheumatol. – 2010; 6: 625–35.
  26. Surh Y., Chun K., Cha H. et al. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NFkappa B activation // Mutat Res. – 2001; 480–481: 243268.
  27. Trentham D., Halpner A., Trentham R. et al. Treatment of rheumatoid arthritis using undenatured type II collagen // Original Internist. – 2002; 9: 12–5.
  28. Wei W., Zhang L., Xu J. et al. A multicenter, double-blind, randomized, controlled phase III Clinical trial of chicken type II collagen in rheumatoid arthritis // Arthritis Res. Ther. – 2009; 11: 180.